14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for ARTL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.41 2.05 %
R2 1.40 1.15 %
R1 1.39 0.598 %
Current price: 1.38
Support S1 1.36 -1.20 %
S2 1.36 -1.76 %
S3 1.34 -2.66 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.63 18.12 %
R2 1.51 9.42 %
R1 1.47 6.52 %
Current price 1.38
Support S1 1.32 -4.71%
S2 1.31 -5.07%
S3 1.28 -7.25%

ARTL Predictions History

2 years ago
JS predicted that ARTL for 2021-09-17 is going $0.793 (-6.71%)

2 years ago
Campbell predicted that ARTL for 2021-09-17 is going

Rank:

3 years ago
jcstockton10.228550 predicted that ARTL for 2021-03-29 is going

Rank:

3 years ago
JS predicted that ARTL for 2021-02-16 is going $2.33 (-12.41%)

3 years ago
Dave Holliday predicted that ARTL for 2021-02-16 is going $1.63 (-38.72%)

Rank:

3 years ago
JS predicted that ARTL for 2021-02-11 is going $1.66 (1.84%)

3 years ago
kushal chhetri predicted that ARTL for 2021-02-11 is going $2.10 (15.38%)

Rank:

3 years ago
JS predicted that ARTL for 2021-02-04 is going $1.20 (-3.23%)

3 years ago
Raymond001 predicted that ARTL for 2021-02-04 is going

Rank:

3 years ago
JS predicted that ARTL for 2021-02-03 is going $1.18 (-7.81%)

Click to get the best stock tips daily for free!

About Artelo Biosciences, Inc.

Artelo Biosciences. Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and ... ARTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT